Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients2018-01-17T17:04:53-05:00
A randomized, double-blind, dosecomparison study of weekly interferon B-1a in relapsing MS A randomized, double-blind, dosecomparison study of weekly interferon B-1a in relapsing MS2018-01-17T17:03:31-05:00
